Coverage
-
August 26, 2016
A New Jersey federal judge agreed Thursday to dismiss Gilead Sciences Inc. and Emory University's suit alleging Indian drugmaker Hetero Drugs Ltd. infringed four patents for HIV treatment Truvada by seeking U.S. Food and Drug Administration approval to make a generic of the drug.
1 other articles on this case.
View all »